Table 6 Health-related resources used for AE-IPF events along the study according to predicted FVC% at baseline
Total N = 28 | FVC < 50% N = 9 | FVC 50–80% N = 16 | FVC > 80% N = 3 | p-value | |
|---|---|---|---|---|---|
Visits | |||||
Primary care visits due to AE-IPF, n (%) | 8 (28.6%) | 4 (44.4%) | 2 (12.5%) | 2 (66.7%) | 0.0760 |
Specialized care visits due to AE-IPF, n (%) | 13 (46.4%) | 4 (44.4%) | 8 (50.0%) | 1 (33.3%) | 1.0000 |
Emergency visits related to AE-IPF, n (%) | 21 (75.0%) | 6 (66.7%) | 14 (87.5%) | 1 (33.3%) | 0.1019 |
Primary care areaa | 6 (28.6%) | 4 (66.7%) | 1 (7.1%) | 1 (100.0%) | 0.0055 |
Hospital care areaa | 20 (95.2%) | 6 (100.0%) | 13 (92.9%) | 1 (100.0%) | 1.0000 |
Hospitalizations | |||||
Hospital admissions due to AE-IPF, n (%) | 21 (75.0%) | 8 (88.9%) | 11 (68.8%) | 2 (66.7%) | 0.4529 |
Number of hospitalizations/event, mean (SD) | 0.79 (0.50) | 0.89 (0.33) | 0.69 (0.48) | 1.00 (1.00) | 0.5133 |
Days of hospitalization, mean (SD) | 8.48 (5.90) | 10.50 (5.48) | 8.17 (6.31) | 4.33 (4.04) | 0.2856 |
ICU admission, n (%)b | 2 (8.7%) | 0 (0.0%) | 2 (16.7%) | 0 (0.0%) | 0.6206 |
Days in ICU, mean (SD) | 18.50 (9.19) | – | 18.50 (9.19) | – | – |
Need for intubation, n (%) | 2 (100.0%) | 0 (0.0%) | 2 (100.0%) | 0 (0.0%) | – |
Tests | |||||
Laboratory tests, n (%)c | 16 (57.1%) | 6 (66.7%) | 8 (50.0%) | 2 (66.7%) | 0.8579 |
Pulmonary function tests, n (%)d | 2 (7.1%) | 0 (0.0%) | 2 (12.5%) | 0 (0.0%) | 0.6190 |
Other tests, n (%)e | 16 (57.1%) | 6 (66.7%) | 8 (50.0%) | 2 (66.7%) | 0.8579 |
Treatments | |||||
Pharmacological treatments for AE-IPF administered, n (%) | 14 (50.0%) | 5 (55.6%) | 7 (43.8%) | 2 (66.7%) | 0.7575 |
Non-pharmacological treatments for AE-IPF administered, n (%) | 6 (21.4%) | 1 (11.1%) | 5 (31.3%) | 0 (0.0%) | 0.4103 |